NJ SR77 | 2014-2015 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on February 5 2015 - 100% progression
Action: 2015-02-05 - Filed with Secretary of State
Text: Latest bill text (Introduced) [HTML]

Summary

Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

Sponsors


Roll Calls

2015-02-05 - Senate - Senate Floor: Third Reading - Final Passage (Voice Vote) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
2015-02-05 - Senate - Senate Third Reading - Final Passage (Voice Vote) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
2014-12-08 - Senate - Senate Health, Human Services and Senior Citizens Committee: Reported Favorably (Y: 8 N: 0 NV: 1 Abs: 0) [PASS]

History

DateChamberAction
2015-02-05SenateFiled with Secretary of State
2015-02-05SenatePassed by the Senate (Voice)
2014-12-08SenateReported from Senate Committee, 2nd Reading
2014-05-19SenateIntroduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Same As/Similar To

AR130 (Same As) 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee

Subjects


New Jersey State Sources


Bill Comments

feedback